Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs is a research paper published in Precision Clinical Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 122 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Heart Association
Grant: 18IPA34170301
National Institutes of Health
Grant: R01/HD088039
NICHD NIH HHS
Grant: R01 HD088039
National Institutes of Health
Grant: 5R01HD088039-05
miRNA as a novel therapeutic target in antenatal nicotine-induced ischemic heart
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Molecular docking and identification of G-protein-coupled receptor 120 (GPR120) agonists as SARS COVID-19 MPro inhibitors
Additional file 1 of Molecular docking and identification of G-protein-coupled receptor 120 (GPR120) agonists as SARS COVID-19 MPro inhibitors
Additional file 1 of Synthesis, characterization, DNA binding interactions, DFT calculations, and Covid-19 molecular docking of novel bioactive copper(I) complexes developed via unexpected reduction of azo-hydrazo ligands
Additional file 1 of Synthesis, characterization, DNA binding interactions, DFT calculations, and Covid-19 molecular docking of novel bioactive copper(I) complexes developed via unexpected reduction of azo-hydrazo ligands